sumatriptan
sumatriptan is listed in the FDA National Drug Code directory with 43 NDC codes, marketed under brand names including sumatriptan, IMITREX, SUMATRIPTAN. Available dosage forms: injection, solution, injection, spray, tablet, film coated.
Drug details
- Generic Name
- sumatriptan
- Brand Names
- sumatriptan, IMITREX, SUMATRIPTAN, TOSYMRA, Sumatriptan
- Application Number
- ANDA090314
- Sponsor
- ONESOURCE SPECIALTY PHARMA LIMITED
- NDC Codes
- 43
- Dosage Forms
- INJECTION, SOLUTION, INJECTION, SPRAY, TABLET, FILM COATED
- Routes
- SUBCUTANEOUS, NASAL, ORAL
- Active Ingredients
- SUMATRIPTAN SUCCINATE, SUMATRIPTAN
Indications and Usage
1 INDICATIONS AND USAGE Sumatriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: • Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with sumatriptan, reconsider the diagnosis of migraine before sumatriptan is administered to treat any subsequent attacks. • Sumatriptan is not indicated for the prevention of migraine attacks. • Safety and effectiveness of sumatriptan tablets have not been established for cluster headache. Sumatriptan is a serotonin (5-HT1B/1D) receptor agonist (triptan) indicated for acute treatment of migraine with or without aura in adults. Limitations of Use: • Use only if a clear diagnosis of migraine headache has been established. (1) • Not indicated for the prophylactic therapy of migraine attacks. (1) • Not indicated for the treatment of cluster headache. (1)